Main Topic Area
All Topic Areas
1 - 10 of 316 more >>
Articles
1 - 1 of 1
- Statement on Generic Oxycodone Hydrochloride
Extended Release Tablets
The Food and Drug Administration today released the following statement on its approval of generic oxycodone hydrochloride extended-release tablets: Oxycodone hydrochloride extended-release products, such as OxyContin and its generic versions, are important options for the management of moderate-to-severe chronic pain, such as that associated with cancer and various other illnesses. FDA's approval of two generic oxycodone hydrochloride products should make this safe and effective medicine...
U.S. Food and Drug Administration
News
1 - 5 of 186 more >>
- Actavis Launches Alprazolam ER Tablets In The U.S.
MedicalNewsToday - Thu, 15 Feb 2007 08:00 EST
- Tekturna(R) - The First New Type Of High Blood Pressure Medicine In More Than A Decade - Receives Its First Approval In The US
MedicalNewsToday - Wed, 07 Mar 2007 08:00 EST
- Lipitor Significantly Reduced The Risk Of Serious Cardiovascular Events Compared With Simvastatin In An 80,000-Patient AnalysisManage
MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST
- Fish haters can get strong bones too
Reuters - Fri, 23 Feb 2007 02:12 EST
- Drug Depot In A Tooth
MedicalNewsToday - Sun, 18 Feb 2007 08:00 EST
Clinical Trials
1 - 5 of 146 more >>
- Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression
ClinicalTrials.gov Identifier: NCT00340379 - Active, not recruiting
Affective Disorders
- Study of the Effectiveness and Tolerability of OROS Hydromorphone HCI SR(Slow-Release) Tablets and Immediate-Release Hydromorphone Tablets in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00410943 - Active, not recruiting
Pain
- PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
ClinicalTrials.gov Identifier: NCT00491998 - Recruiting
Parkinson's Disease
- Post-Operative Haloperidol Versus Placebo for Prevention of Post-Operative Delirium After Acute Hip Surgery.
ClinicalTrials.gov Identifier: NCT00250237 - Recruiting
Post-Operative Delirium; Hip Fracture
- A Comparison of Study Drug with Placebo and Haloperidol in Patients With Schizophrenia
ClinicalTrials.gov Identifier: NCT00044044 - Active, not recruiting
Schizophrenia

Not Signed In -

